Experimental cell therapy trial launches for Tough-to-Treat cancers

This early-stage study is testing a new cell therapy called GK01, given alongside an existing immunotherapy drug, for people with advanced solid tumors that have spread or returned. The main goal is to check if this combination is safe and how the body processes it, while also looking for early signs that it might help control the cancer. It's a small trial enrolling 15 adults with various advanced cancers who haven't responded to standard treatments.